Selective inhibition of human translation termination by a drug-like compound
The drug-like compound PF846 and its derivatives inhibit the translation of specific mRNAs by the human ribosome. Here the authors show how PF846 arrests translation at the stop codon by slowing hydrolysis of the protein nascent chain at the ribosome P-site tRNA by eukaryotic release factor 1 (eRF1)...
Enregistré dans:
Auteurs principaux: | Wenfei Li, Stacey Tsai-Lan Chang, Fred. R. Ward, Jamie H. D. Cate |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b86e399a4ec045d89db7d9e3ea9c2b22 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Structure of ribosome-bound azole-modified peptide phazolicin rationalizes its species-specific mode of bacterial translation inhibition
par: Dmitrii Y. Travin, et autres
Publié: (2019) -
Mechanisms of drug interactions between translation-inhibiting antibiotics
par: Bor Kavčič, et autres
Publié: (2020) -
Structural basis of suppression of host translation termination by Moloney Murine Leukemia Virus
par: Xuhua Tang, et autres
Publié: (2016) -
Pin1 inhibition improves the efficacy of ralaniten compounds that bind to the N-terminal domain of androgen receptor
par: Jacky K. Leung, et autres
Publié: (2021) -
Translational coupling via termination-reinitiation in archaea and bacteria
par: Madeleine Huber, et autres
Publié: (2019)